Symbotic (US:SYM)2025-11-24 23:02Financial Data and Key Metrics Changes - For the full fiscal year 2025, the company reported a revenue increase of 26% year over year, with fourth-quarter revenue growing 10% year over year to $618 million [4][10] - The net loss for the fourth quarter was $19 million, compared to a net income of $16 million in the same quarter of fiscal year 2024 [10] - Adjusted EBITDA for the fourth quarter was $49 million, up from $42 million in the fourth quarter of fiscal year 2024 [10] - Cash on the balance sheet exceeded $1.2 billion, up from $778 million in the fiscal third quarter [13] Business Line Data and Key Metrics Changes - Software revenue grew 57% year over year to $9.3 million in the fourth quarter, while operation services revenue increased 21% year over year to $26.9 million [12] - The backlog remained strong at $22.5 billion, with an increase from $22.4 billion in the previous quarter [10][11] Market Data and Key Metrics Changes - The company signed a new customer, Medline, marking its entry into the healthcare vertical, which has significant potential due to the large number of healthcare distribution centers in the U.S. [8] - The company is expanding its reach with GreenBox, signing new sites in Dallas and Chicago, extending coverage from California to the Midwest and Southeast [7][8] Company Strategy and Development Direction - The company aims to harness its growing product portfolio to broaden opportunities, particularly in e-commerce with its micro-fulfillment solution [9] - Key objectives for fiscal year 2026 include unlocking higher margins and continuing investment in innovation to support future growth [9] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the growing sales pipeline and the ability to deliver higher value through innovative technology and improved installation efficiency [6][9] - The introduction of next-generation storage technology is expected to impact revenue phasing throughout fiscal year 2026, with less pronounced growth in the first half and a ramp-up in the second half [14][20] Other Important Information - The company is focused on improving operational efficiencies and reducing installation times, which are expected to generate significant savings for customers [6][7] - Management highlighted the importance of attracting and retaining talent, with strategic investments in R&D to support the expanding product portfolio [13][48] Q&A Session Summary Question: Can you provide more color on the Medline relationship and its potential? - Management indicated that the relationship with Medline was developed over a year, focusing on the unique capabilities of their system to meet healthcare needs [17] Question: What is the expectation for ramping next-gen systems? - Management confirmed that the ramp-up for next-gen systems is expected to occur in the second half of fiscal 2026, with stable revenue in the first half [20] Question: Can you discuss the specifics of the Medline project? - The initial engagement with Medline is a proof of concept at one site, with potential for future expansion based on performance [23] Question: How is the company addressing the backlog and new customer opportunities? - Management emphasized that while they do not guide on backlog, they are optimistic about new customer acquisitions and the potential for growth in 2026 [34] Question: What are the implications of the new battery technology partnership? - The partnership with Nyobolt is expected to enhance the reliability of bots, particularly in regions with erratic power supply [70] Question: How does the company view its expansion into Europe? - Management is optimistic about opportunities in Europe, with half of the sales team already engaged there [73]